Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

SHOULDER INNOVATIONS, INC. (SI) Cash Flow Statement

SHOULDER INNOVATIONS, INC. (SI) generated -$37.1M of operating cash flow over the twelve months to 2026-06-30, spent $10.0M on capital expenditure and had free cash flow of -$47.1M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SISHOULDER INNOVATIONS, INC.Follow SI — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
409.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days
LineFY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-14.1-28.6-37.1
Capital expenditure4.07.4-10.0
Free cash flow-18.2-36.0-47.1
Stock-based compensation0.81.0—

USD millions · SEC XBRL

SHOULDER INNOVATIONS, INC. — questions

What is SHOULDER INNOVATIONS, INC.'s operating cash flow?
-$37.1M over the twelve months to 2026-06-30.
How much does SHOULDER INNOVATIONS, INC. spend on capital expenditure?
$10.0M over the twelve months to 2026-06-30.
What is SHOULDER INNOVATIONS, INC.'s free cash flow?
-$47.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from SHOULDER INNOVATIONS, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.